The Harvard Law School Library staff invite you to attend a book talk and discussion in celebration of Nudging Health: Health Law and Behavioral Economics (I. Glenn Cohen, Holly Fernandez Lynch, and Christopher T. Robertson, eds., with Foreword by Cass R. Sunstein)(Johns Hopkins Univ. Press, Nov. 2016). Professor Cohen and Holly Fernandez Lynch will be joined by panelists including: Jerry Avorn, MD, Professor of Medicine, Harvard Medical School and Chief of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital; Abigail R. Moncrieff, Associate Professor of Law and Peter Paul Career Development Professor, Boston University School of Law; and Cass R. Sunstein, Robert Walmsley University Professor, Harvard Law School.
Copies of Nudging Health will be available for sale. Professor Cohen, Professor Sunstein, and Holly Fernandez Lynch will be available for signing books at the end of the talk.
Wednesday, November 16, 2016 at noon, with lunch
Harvard Law School Room WCC 2036 Milstein East B/C (Directions)
1585 Massachusetts Ave., Cambridge
“Behavioral nudges are everywhere: calorie counts on menus, automated text reminders to encourage medication adherence, a reminder bell when a driver’s seatbelt isn’t fastened. Designed to help people make better health choices, these reminders have become so commonplace that they often go unnoticed. In Nudging Health, forty-five experts in behavioral science and health policy from across academia, government, and private industry come together to explore whether and how these tools are effective in improving health outcomes.
Behavioral science has swept the fields of economics and law through the study of nudges, cognitive biases, and decisional heuristics—but it has only recently begun to impact the conversation on health care. Nudging Health wrestles with some of the thorny philosophical issues, legal limits, and conceptual questions raised by behavioral science as applied to health law and policy. The volume frames the fundamental issues surrounding health nudges by addressing ethical questions. Does cost-sharing for health expenditures cause patients to make poor decisions? Is it right to make it difficult for people to opt out of having their organs harvested for donation when they die? Are behavioral nudges paternalistic? The contributors examine specific applications of behavioral science, including efforts to address health care costs, improve vaccination rates, and encourage better decision-making by physicians. They wrestle with questions regarding the doctor-patient relationship and defaults in healthcare while engaging with larger, timely questions of healthcare reform.
Nudging Health is the first multi-voiced assessment of behavioral economics and health law to span such a wide array of issues—from the Affordable Care Act to prescription drugs.” — Johns Hopkins University Press
About I. Glenn Cohen
Professor Cohen is one of the world’s leading experts on the intersection of bioethics (sometimes also called “medical ethics”) and the law, as well as health law. He also teaches civil procedure. Professor Cohen’s current projects relate to big data, health information technologies, mobile health, reproduction/reproductive technology, research ethics, organ transplantation, rationing in law and medicine, health policy, FDA law, translational medicine, and to medical tourism – the travel of patients who are residents of one country, the “home country,” to another country, the “destination country,” for medical treatment.
He is the author of more than 80 articles and chapters and his award-winning work has appeared in leading legal (including the Stanford, Cornell, and Southern California Law Reviews), medical (including the New England Journal of Medicine, JAMA), bioethics (including the American Journal of Bioethics, the Hastings Center Report), scientific (Science, Cell, Nature Reviews Genetics) and public health (the American Journal of Public Health) journals, as well as Op-Eds in the New York Times and Washington Post. Cohen is the editor of The Globalization of Health Care: Legal and Ethical Issues (Oxford Univ. Press, 2013, the co-editor of Human Subjects Research Regulation: Perspectives on the Future (MIT Press, 2014, co-edited with Holly Lynch, Identified Versus Statistical Lives: An Interdisciplinary Perspective (Oxford Univ. Press, 2015, co-edited with Norman Daniels and Nir Eyal, FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies (Columbia Univ. Press, 2015, co-edited with Holly Lynch, The Oxford Handbook of U.S. Health Care Law (Oxford Univ. Press, 2015-2016, co-edited with William B. Sage and Allison K. Hoffman) and the author of Patients with Passports: Medical Tourism, Law, and Ethics (Oxford Univ. Press, 2014).
Cohen was selected as a Radcliffe Institute Fellow for the 2012-2013 year and by the Greenwall Foundation to receive a Faculty Scholar Award in Bioethics. He is also a Fellow at the Hastings Center, the leading bioethics think tank in the United States. He is currently one of the key co-investigators on a multi-million Football Players Health Study at Harvard which is committed to improving the health of NFL players. He leads the Ethics and Law initiative as part of the multi-million dollar NIH funded Harvard Catalyst | The Harvard Clinical and Translational Science Center program. He is also one of three editors-in-chief of the Journal of Law and the Biosciences, a peer-reviewed journal published by Oxford University Press and serves on the editorial board for the American Journal of Bioethics. He serves on the Steering Committee for Ethics for the Canadian Institutes of Health Research (CIHR), the Canadian counterpart to the NIH.
About Holly Fernandez Lynch
Holly Fernandez Lynch, JD, MBioethics, is Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. She is responsible for oversight of the Center’s sponsored research portfolio, event programming, fellowships, student engagement, development, and a range of other projects and collaborations. She is Co-Lead of the Law and Ethics Initiative of the Football Players Health Study at Harvard University, Co-Lead of the Center’s Involvement with the Regulatory Foundations, Ethics, and Law Program of Harvard Catalyst | The Harvard Clinical and Translational Science Center, and co-investigator of the PCORI-funded project “Research Ethics in Patient-Centered Outcomes Research.” In addition, she is Co-Editor of the Center’s collaborative health policy blog, Bill of Health.
Holly’s scholarship focuses on law, bioethics, and health policy, in particular the regulation and ethical conduct of research with human subjects and conflicts of conscience in health care. She published Conflicts of Conscience in Health Care: An Institutional Compromise in 2008 (MIT Press), and has released two co-edited volumes stemming out of Petrie-Flom Center conferences, Human Subjects Research Regulation: Perspectives on the Future (MIT Press 2014) and FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies (Columbia Univ. Press 2015).
Holly is faculty at the Harvard Medical School Center for Bioethics, where she co-teaches a course on “Health Law, Policy, and Bioethics.” In 2014, Holly was appointed as a member of the Secretary’s Advisory Committee on Human Research Protections (SACHRP), U.S. Department of Health and Human Services.
Holly previously practiced FDA law at Hogan & Hartson, LLP (now Hogan Lovells) in Washington, DC. In addition, Holly has government experience as a bioethicist working with the Human Subjects Protection Branch at the NIH’s Division of AIDS. She was also Senior Policy and Research Analyst for President Obama’s Commission for the Study of Bioethical Issues, where she worked on Ethically Impossible: STD Research in Guatemala from 1946-1948. Holly has served as a member of the Institutional Review Board at The Fenway Institute, and as a member of expert working groups at the Multi-Regional Clinical Trials Center at Harvard.
Jerry Avorn, MD, Professor of Medicine, Harvard Medical School and Chief of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital
Abigail R. Moncrieff, Associate Professor of Law and Peter Paul Career Development Professor, Boston University School of Law
Cass R. Sunstein, Robert Walmsley University Professor, Harvard Law School